Novartis Home
At Novartis, we are reimagining medicine
Novartis Financial Results – Q3 2020
Novartis announced the company’s financial results for the third quarter of 2020.
Video - Financial Results Q3 2020
Our CEO Vas Narasimhan reflects on our Q3 results and comments on our sustained efforts to combat COVID-19 and progress on our ESG commitments.
Novartis COVID-19 Information Center
Novartis is responding to the coronavirus disease (COVID-19) outbreak. The information center provides a central hub for news, guidance and resources.
Abstract summaries at EADV
Discover some of the scientific data we are presenting this year at the European Academy of Dermatology and Venereology (EADV) Virtual Congress 2020.
1_4y4ere9u
Our people, our stories, our culture on @novartislife Instagram
Find out more about our Inspired, Curious and Unbossed culture as we celebrate our people who are reimagining medicine and their stories on our new community channel @novartislife.
Cell & Gene Therapy Explained
What if medicine for certain diseases only needed to be taken once?
AveXis renamed Novartis Gene Therapies, signifying the growing importance of gene therapy to Novartis corporate strategy
Our commitment to doing what's right
Novartis is committed to ensuring our associates are empowered to do what’s right. On September 01, 2020, we introduced a new Code of Ethics for Novartis.